Literature DB >> 20431968

Approach to dysphagia in the young patient in the era of eosinophilic esophagitis.

Nirmala Gonsalves1.   

Abstract

Eosinophilic esophagitis (EoE) has emerged as an important cause of dysphagia and food impactions in young adults. Previously considered a rare condition, an increasing number of cases of EoE have been attributable to a rising incidence and a growing awareness of the condition. Typical endoscopic features include concentric mucosal rings, linear furrowing, white exudates, and a narrow caliber esophagus. Current consensus guidelines define EoE by 1) the presence of characteristic symptoms, especially dysphagia and food impactions in adults, 2) >or= 15 eosinophils per high power field in esophageal tissue, and 3) exclusion of other disorders with similar presentations (eg, gastroesophageal reflux disease). Current knowledge about the pathophysiology implicates food allergens, aeroallergens, and genetic factors. The main treatment options for EoE are proton pump inhibitors, dietary manipulation, and topical or oral glucocorticoids. Endoscopic dilation may be performed in patients who do not respond to medical therapy. This review highlights recent insights into the diagnosis and management of EoE in young adults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431968     DOI: 10.1007/s11894-010-0101-8

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  55 in total

1.  Three brothers with dysphagia caused by eosinophilic esophagitis.

Authors:  Sonal M Patel; Kenneth R Falchuk
Journal:  Gastrointest Endosc       Date:  2005-01       Impact factor: 9.427

2.  Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids.

Authors:  C A Liacouras; W J Wenner; K Brown; E Ruchelli
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-04       Impact factor: 2.839

3.  The ringed esophagus: histological features of GERD.

Authors:  J B Morrow; J J Vargo; J R Goldblum; J E Richter
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

4.  Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis.

Authors:  Sandeep K Gupta; Joseph F Fitzgerald; Tamara Kondratyuk; Harm HogenEsch
Journal:  J Pediatr Gastroenterol Nutr       Date:  2006-01       Impact factor: 2.839

5.  Topical corticosteroid treatment of dysphagia due to eosinophilic esophagitis in adults.

Authors:  Amindra S Arora; Jean Perrault; Thomas C Smyrk
Journal:  Mayo Clin Proc       Date:  2003-07       Impact factor: 7.616

6.  Esophageal eosinophilia in children with dysphagia.

Authors:  Ka Ming Cheung; Mark R Oliver; Donald J S Cameron; Anthony G Catto-Smith; Chung W Chow
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-10       Impact factor: 2.839

7.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study.

Authors:  Subra Kugathasan; Robert H Judd; Raymond G Hoffmann; Janice Heikenen; Gregorz Telega; Farhat Khan; Sally Weisdorf-Schindele; William San Pablo; Jean Perrault; Roger Park; Michael Yaffe; Christopher Brown; Maria T Rivera-Bennett; Issam Halabi; Alfonso Martinez; Ellen Blank; Steven L Werlin; Colin D Rudolph; David G Binion
Journal:  J Pediatr       Date:  2003-10       Impact factor: 4.406

8.  Histopathologic variability in children with eosinophilic esophagitis.

Authors:  Ameesh Shah; Amir F Kagalwalla; Nirmala Gonsalves; Hector Melin-Aldana; B U K Li; Ikuo Hirano
Journal:  Am J Gastroenterol       Date:  2009-02-10       Impact factor: 10.864

9.  Eosinophilic oesophagitis: a novel treatment using Montelukast.

Authors:  S E A Attwood; C J Lewis; C S Bronder; C D Morris; G R Armstrong; J Whittam
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Clinical and endoscopic features of eosinophilic esophagitis in adults.

Authors:  John Croese; Stephen K Fairley; John W Masson; André K H Chong; David A Whitaker; Peter A Kanowski; Neal I Walker
Journal:  Gastrointest Endosc       Date:  2003-10       Impact factor: 9.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.